[Immunoreactivity of synthetic peptides, corresponding to B-cellular epitopes of human type I T-lymphotrophic virus structural proteins]

Mol Biol (Mosk). 1993 Jul-Aug;27(4):880-7.
[Article in Russian]

Abstract

The immunoreactivity of 25 synthetic peptides corresponding to amino acid fragments of the HTLV-I structural proteins p19 gag, gp46 and gp21 env were studied in enzyme linked immunosorbent assay using a serum panel of 70 reference positive specimens with anti-HTLV-I antibodies. The location of the synthetic peptides containing the B-cell epitopes of HTLV-I was established. Anti-HTLV-I antibodies effectively recognized these peptides. The significance of some amino acids for forming the HTLV-I antigenic determinants was estimated. The synthetic peptides with amino acid sequences 100-130 p19 gag and 176-201 gp46 env were found to have most immunoreactivity (90-99% recognition by sera of HTLV-I infected patients) and mimic the immunodominant B-cell epitopes of HTLV-I structural proteins.

Publication types

  • English Abstract

MeSH terms

  • Amino Acid Sequence
  • B-Lymphocytes / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • HTLV-I Antibodies / immunology
  • Human T-lymphotropic virus 1 / immunology
  • Human T-lymphotropic virus 1 / metabolism*
  • Humans
  • Immunodominant Epitopes / immunology*
  • Molecular Sequence Data
  • Peptides / metabolism*
  • Sequence Homology, Amino Acid
  • Viral Structural Proteins / immunology*

Substances

  • HTLV-I Antibodies
  • Immunodominant Epitopes
  • Peptides
  • Viral Structural Proteins